Our Coffee Chat event is coming back to Irvine, again! Come and join us for a conversation with Dr. Albert Hsieh and Stan Yang about their career trajectory and their entrepreneurship. Limited space for 25 attendees. Please register using the Eventbrite page.
Albert Hsieh, Ph.D.
Dr. Hsieh is passionate to develop precision diagnostics tools to improve human’s health in the past 20 years. He founded Genpedia, which endeavors to develop benchtop robotic system with assay for sample prep of liquid biopsy.
He has multidisciplinary practical experience in developing biomedical devices, such as endoscopic OCT for GI track tumor (Beckman Laser Institute), Digital PCR biochip (ITRI), sample-to-answer biochip (GenMark), automation system for sample preparation of NGS (Invitrogen/Life Technologies, Illumina), and Hemostasis analysis biochip, etc.
He has also worked as a salesman/customer engineer in marketing department of electronics and semiconductor companies, as well as a R&D Engineer in Micro System Lab of Industrial Technology Research institute while he was in Taiwan. Dr. Hsieh received his doctoral degree in engineering from UC Irvine, master’s degree from Chemical Engineering and Material Science Dept. of USC.
Stan Yang, Ph.D
Dr. Stan Yang has 36 years experience in the field of implantable devices, including 16 years in intraocular lenses, and 20 years in tissue regeneration materials. He has led projects from conception, to regulatory approval, production and commercialization.
He is the key inventor of 23 patents, including 20 patents in the field of IOL, and 2 patents in tissue regeneration. Dr. Stan Yang is the founder of Unicare Biomedical, Inc. (www.unicarebiomedical.com), which manufactures and distributes tissue regeneration products for dental and orthoepedic applications.
Dr. Yang received his EMBA from University of California, Irvine and PhD degree in polymer science from University of Akron, Ohio.
Antonio Lamb, CEO and co-founder of MicroSynbiotiX
Antonio is a plant molecular biologist and entrepreneur. He graduated from the University of California, Santa Cruz in 2015, where he studied computational biology and molecular biology. He is a cofounder of MicroSynbiotiX, an award-winning algal synthetic biology startup that is developing microalgae as a new drug delivery platform for the aquatic animal health industry. Since founding MicroSynbiotiX, Antonio has raised more than 1 million dollars in venture funding for the company and has won numerous awards and grants for the business. Antonio’s interests also include exploring ways to make science more accessible to the public and is an advocate for citizen science.
SoCal TBA 2019 kickoff networking event! Come and join us for a conversation with Dr. Nicole Weng about her career trajectory and her current role as a clinical development scientist.